Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mechanotransduction governs CD40 function and underlies X-linked Hyper IgM syndrome

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.23.550231Source: DataRank Database

Mechanotransduction governs CD40 function and underlies X-linked Hyper IgM syndrome is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (14)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Stefano Travaglino ORCID,Matthias Münchhalfen ORCID,Richard Görg ORCID,Zhe Zhong ORCID,Jintian Lyu

Live enrichment

PubMed:26207759

National Institutes of Health

Grant: 5R01LM013039-02

HealthyMe/MiSalud Smartphone Application: Identifying Mechanisms to Engage African Americans and Hispanics in Personal Health Libraries

National Institutes of Health

Grant: 5R01CA266052-04

Hydrogel-based Organoids of African-American Lymphomas to Study B Cell Receptor Pathway Inhibitors

National Institutes of Health

Grant: 5U01CA280984-03

Dysregulated mechanoimmunology of epigenetics-driven lymphomas

National Institutes of Health

Grant: 5U01CA250040-05

Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy

National Institutes of Health

Grant: 5R01CA238745-05

Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas

greenLicense: http://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (http://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/07/25/2023.07.23.550231.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.07.23.550231

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10401940

https://doi.org/10.1101/2023.07.23.550231

https://doi.org/10.1126/sciadv.adl5815

Fields of Study

0301 basic medicine03 medical and health sciences

Keywords

B-LymphocytesHyper-IgM Immunodeficiency Syndrome, Type 1T-LymphocytesCD40 LigandMechanotransduction, CellularMiceMutationHumansAnimalsBiomedicine and Life SciencesCD40 AntigensSignal Transduction